Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2005
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082894A1 Cell targeting conjugates
09/09/2005WO2005082889A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082870A1 Abc transporter inhibitor
09/09/2005WO2005082867A1 Novel 1,2,4-benzotriazine-1,4-dioxides
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082845A1 Novel therapies with somatostatin receptor agonists
09/09/2005WO2005082844A1 Treatment of diseases by using a somatostatin receptor agonist
09/09/2005WO2005082459A2 Method of decreasing blood cells
09/09/2005WO2005082412A1 Drug for treating and preventing cancer
09/09/2005WO2005082394A1 Phosphorylation inhibitors for insulin receptor
09/09/2005WO2005082392A1 Tumor cell-specific growth inhibitor comprising ashwagandha leaf extract
09/09/2005WO2005082389A1 Cancer metastasis inhibitory composition
09/09/2005WO2005082373A1 Medicinal eudistomin derivative composition
09/09/2005WO2005082357A1 Use of beta-lapachone for treating hematologic tumors
09/09/2005WO2005082079A2 Tetracyclic lactam derivatives and uses thereof
09/09/2005WO2005027973A3 Combinations of a vegf receptor inhibitor with other therapeutic agents
09/09/2005WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
09/09/2005WO2005012358A3 Use of adcc-optimized antibodies for treating weak patients
09/09/2005WO2005011725A3 Anti-angiogenetic agent and its use, in particular in cancer treatment
09/09/2005WO2005007085A3 Pyrazolo pyrimidine derivatives and methods of use thereof
09/09/2005WO2005000320A3 Use of double-stranded ribonucleic acid for inducing cell lysis
09/09/2005WO2004111090A3 Molecules for targeting and releasing therapeutic compounds, and the use thereof
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2841741A1 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005CA2599304A1 Cell targeting conjugates
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2557326A1 Combination of ad-p53 and chemotherapy for the treatment of tumours
09/09/2005CA2557093A1 Cancerous disease modifying antibodies
09/09/2005CA2557091A1 Cancerous disease modifying antibodies
09/09/2005CA2556794A1 Use of beta-lapachone as a broad spectrum anti-cancer agent
09/09/2005CA2556789A1 Use of beta-lapachone for treating hematologic tumors
09/09/2005CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005CA2556759A1 Beta-lapachone and s-phase drug combinations for cancer treatment
09/09/2005CA2556758A1 Use of beta-lapachone for treating or preventing cancer
09/09/2005CA2556738A1 Tetracyclic lactam derivatives and uses thereof
09/09/2005CA2556729A1 Muc1 antagonist enhancement of death receptor ligand-induced apoptosis
09/09/2005CA2556616A1 Compounds as inhibitors of cell proliferation and viral infections
09/09/2005CA2555950A1 Use of beta-lapachone for the treatment of pancreatic cancer
09/09/2005CA2555941A1 Use of beta-lapachone for treatment of colon cancer
09/09/2005CA2555724A1 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
09/09/2005CA2555720A1 Isoquinoline derivatives
09/09/2005CA2555245A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005CA2553895A1 Use of substituted 1,2,3 indolizine derivatives for treatingdiseases associated with a pathological choroidal angiogenesis
09/09/2005CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197349 Pyrrolo[2,3-D]pyrimidine compounds
09/08/2005US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse
09/08/2005US20050197339 Di-substituted pyrrolotrizine compounds
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent
09/08/2005US20050197323 Full or partial glucocorticosteroid replacement therapy for obstructive pulmonary bronchial diseases
09/08/2005US20050197314 Synergistic combination of immunostimulatory CpG oligonucleotides and the immunopotentiating cytokine Flt3 ligand; immunotherapy of tumors, viral infections; cancer vaccines
09/08/2005US20050196860 Novel EPS8 compounds for therapy and diagnosis and methods for using same
09/08/2005US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening
09/08/2005US20050196793 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers
09/08/2005US20050196443 Pulsatile release compositions and methods for enhanced intestinal drug absorption
09/08/2005US20050196401 Energy-activated targeted cancer therapy
09/08/2005US20050196385 Lymphocytic cells; industrial production of functional cells, pharmaceutical quality, large amounts; blood, plasma, serum from cytapheresis, frozen stock; cultured with synthetic activators phosphohalohydrin, phosphoepoxide, bisphosphonate,cytokine, interlukin; treat infection, parasites, cancer
09/08/2005DE60110057T2 Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung Liposomes containing an entrapped compound in solution übersattigter
09/08/2005DE102004008417A1 Pharmaceutical active substance, for the treatment of cancers of liver, colon and kidney, comprises a peptide toxin, enzymes and alternatively antagonistically and/or synergistically active substance
09/07/2005EP1571211A1 Antibodies against lesion tissue
09/07/2005EP1571148A1 3-phenyl-cinnoline homologue and antitumor agent containing the same
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/07/2005EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor
09/07/2005EP1570849A1 Freeze-dried preparation of stabilized anthracycline compound
09/07/2005EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use
09/07/2005EP1570089A1 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same
09/07/2005EP1569954A1 Cyanomethyl derivatives as cysteine protease inhibitors
09/07/2005EP1569946A1 Colchicine derivatives, preparation method and use thereof
09/07/2005EP1569928A1 Therapeutic compounds and methods
09/07/2005EP1569907A1 Nicotinamide-based kinase inhibitors
09/07/2005EP1569692A2 Betaine and salicylic acid compositions
09/07/2005EP1569689A2 Combination il2/anti-her2-antibody therapy for cancers characterized by overexpression of the her2 receptor protein
09/07/2005EP1569660A2 C-type lectin binding molecules, identification and uses thereof
09/07/2005EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
09/07/2005EP1569657A1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis
09/07/2005EP1569656A2 Phosphoantigens for regulating an immune response
09/07/2005EP1569644A2 Indolizine compounds
09/07/2005EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
09/07/2005EP1569616A2 An exopolysaccharides delivery system for active molecules
09/07/2005EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
09/07/2005EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1455760B1 Ultrapure oral fludara formulation with a fast releasing active substance
09/07/2005EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/07/2005EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors
09/07/2005EP1328519B1 Orally active salts with tyrosine kinase activity
09/07/2005EP1282621B1 Vitronectin receptor antagonists
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
1 ... 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 ... 2211